Turtle Creek Wealth Advisors’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.72M Buy
18,786
+5,949
+46% +$521K 0.09% 125
2026
Q1
$1.09M Buy
12,837
+1,576
+14% +$140K 0.08% 138
2025
Q4
$890K Buy
11,261
+4,186
+59% +$328K 0.07% 165
2025
Q3
$566K Buy
7,075
+3,371
+91% +$288K 0.05% 198
2025
Q2
$337K Buy
+3,704
New +$338K 0.04% 208
2024
Q1
Sell
-925
Closed -$73.7K 309
2023
Q4
$73.7K Buy
+925
New +$69.5K 0.02% 226

Other funds holding CL

Turtle Creek Wealth Advisors's CL Position: Q2 2026 in Review

Turtle Creek Wealth Advisors increased its Colgate-Palmolive (CL) stake by 46% in Q2 2026, buying an estimated $521K and bringing the position to 18,786 shares worth $1.72M. The position accounts for 0.09% of the portfolio, ranked #125.

Turtle Creek Wealth Advisors first reported a position in CL in Q4 2023 and has held it in 6 quarters since. 706 funds tracked by Wall St. Rank hold CL as of Q2 2026.

  • Turtle Creek Wealth Advisors held 18,786 shares of Colgate-Palmolive worth $1.72M as of Q2 2026.
  • Turtle Creek Wealth Advisors bought 5,949 Colgate-Palmolive shares in Q2 2026, an estimated $521K.
  • Colgate-Palmolive made up 0.09% of Turtle Creek Wealth Advisors's portfolio in Q2 2026, its #125 holding.
  • Turtle Creek Wealth Advisors first reported a position in Colgate-Palmolive in Q4 2023 and has held it in 6 quarters since.
  • 706 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q2 2026.

Based on Turtle Creek Wealth Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.